SIML - Simlatus Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.0001
0.0000 (0.00%)
At close: 3:40PM EST
Stock chart is not supported by your current browser
Previous Close0.0001
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0001
52 Week Range0.0000 - 0.0840
Volume11,264,495
Avg. Volume99,695,086
Market Cap447,435
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    SIML Will Manufacture the World’s First Hybrid CBD Extraction System

    SAN FRANCISCO, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that Proscere Bioscience has secured the rights to manufacture a CBD - Hybrid Extraction System with integrated cold-water and alcohol extraction technologies. Proscere Bioscience will manufacture the world’s first Hybrid Cold-Water/Alcohol Extraction System for CBD. Richard Hylen, CEO, stated, “Having secured the technological rights to build and bring to market the world’s first Hybrid Extraction System for CBD is certainly a game changer for the Company.

  • GlobeNewswire

    SIML Chairman Announcement

    San Francisco, California, Oct. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), Richard Hylen, Chairman and CEO, has made the following announcement. “In the past year Simlatus has acquired Satel Group and Proscere Bioscience. With this said, I was appointed as the Chairman and CEO of Simlatus on October 31, 2018.

  • GlobeNewswire

    SIML Will Design World’s First Hybrid CBD Extraction System

    San Francisco, California, Oct. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that Proscere Bioscience will have the rights to manufacture a hybrid CBD Extraction System which combines cold-water extraction with alcohol extraction. Richard Hylen, CEO, stated, “We now have the technology rights to build a CBD extraction system that can process bio-mass through a cold-water extraction processing system first, and through an alcohol extraction system second.

  • GlobeNewswire

    SIML Receives Green-Light to Build and Deliver $24M in CBD Extraction Systems

    San Francisco, California, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that certifications and manufacturing processes are initiated to commence the manufacturing and delivery pursuant the purchase orders for the CBD Extraction Systems. Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact.

  • GlobeNewswire

    SIML Continues to Pay Off Convertible Notes While Finalizing Delivery of $24M in CBD Orders

    San Francisco, California, Sept. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that between March and August of this year it has prepaid 5 notes for a total principal, interest and penalties of over $2M. Pursuant the 8K filing of September 16, 2019, the company is finalizing the delivery of 14 CBD Extraction Systems in value of $24M. Richard Hylen, CEO, stated, “Whenever possible, we have been prepaying convertible notes and retiring any reserves and shares back to treasury.

  • GlobeNewswire

    SIML Proscere Bioscience in Negotiations With Major Pharmaceutical Company for a $200M Deal

    Grass Valley, CA, Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) ("Simlatus" or the "Company") announces today negotiations with a major pharmaceutical company in Europe regarding a potential $200M initial order. The company initially discussed its Hybrid Cold/Water – Alcohol based CBD Extraction system in Europe last December-2018 with a major pharmaceutical company. Negotiations are gaining ground while Proscere Bioscience is positioning itself to supply the pharmaceutical industry with CBD extraction systems to produce pharmaceutical-grade THC and CBD as a replacement for opiate based Schedule-II prescription drugs.

  • GlobeNewswire

    Chairman Richard Hylen Shares Positive Updates with Shareholders

    Richard Hylen, CEO and Chairman, stated, “Since my appointment starting in late 2018 , our company has demonstrated growth in revenue and sales for all 3 of our subsidiaries. Mr. Hylen further stated, “Proscere Bioscience continues to demonstrate strong growth in the growing CBD industry, with our focus on fulfilling $20M+ in purchase orders for our CBD Extraction systems.

  • GlobeNewswire

    SIML Retires $400,000 in Convertible Debt With Sales Over $20M During the First Half of 2019

    San Francisco, California, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) today announces that the Company entered into a Release Agreement in July 2019 and agreed to pre-pay the entire balance of a convertible note dated January 31, 2019 with the original principal amount of $33,000 between Emunah Funding, LLC and SIML. About SIML: While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry with sales over $20M during the first half of 2019 for its Cold-Water Extraction System. Satel Group is one of only a handful of companies holding AT&T contracts to service multi-dwelling units throughout large metropolitan areas in the USA with DirecTV services.

  • GlobeNewswire

    SIML Proscere Bioscience Positions Long Term Strategy

    San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.

  • GlobeNewswire

    SIML Proscere Bioscience Waltzing With Largest Cannabis Processor

    San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.

  • Newsfile

    The Game Changing High Demand for CBD/Hemp Drives Revenue and Acquisitions

    Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - July 9, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a multimedia snapshot reporting on the movement surrounding CBD/hemp business acquisitions based on continued growth in consumer and industrial demand in both the US and internationally. Read the full article on Investorideas.com https://www.investorideas.com/News/2019/cannabis/07090CBD-Hemp.aspFior Markets said in its recent report, 'the global industrial hemp market is expected to grow ...

  • GlobeNewswire

    SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Industry With NASDAQ on the Horizon

    San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.

  • Newsfile

    Cannabis Acquisitions Pave the Way for Future Growth Building out Technology, Distribution and Revenues

    Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - July 1, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a multi-media snapshot reporting on recent acquisitions in the CBD cannabis space, featuring Simlatus Corporation (OTC PINK: SIML).Read the full article discussing acquisitions in the CBD cannabis space on Investorideas.com https://www.investorideas.com//News/2019/cannabis/07010Acquisitions.aspViridian's Deal Tracker recently noted, "Acquisitions of companies in the hemp sector accelerate worldwide as industrial and ...

  • GlobeNewswire

    Simlatus Uses Its Cash to Retire More Debt and Reports New Revenues on All Fronts

    SAN FRANCISCO, CA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams in the CBD industry. Proscere Bioscience is the company’s division focused on the CBD industry.

  • GlobeNewswire

    Simlatus No Longer Shell-Risk & Retires $1.7M in Convertible Debt

    SAN FRANCISCO, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry, announces today that Chairman and CEO, Richard Hylen, has provided the following statements. Richard Hylen, Chairman and CEO, stated, “Simlatus Corporation is no longer considered a Shell-Risk by OTC Markets.  The Company’s most recent disclosure statements and Balance Sheet indicate satisfactory revenue and assets.  We need to prove to our shareholders and investors a vote of confidence by the Markets and that our Company is on a sound path for the future.

  • GlobeNewswire

    SIMLATUS RETIRES $600,000 OF CONVERTIBLE DEBT

    Pursuant with the Form-8K filed today, the company has settled and retired to treasury approximately $600,000 in convertible debt. Richard Hylen, Chairman and CEO, stated, “I listen to our shareholders and pay attention to our market concerns.

  • GlobeNewswire

    Proscere Bioscience Receives a $2.8M Order to Build Cold-Water CBD/Hemp Extraction Systems for United Opportunities, LLC

    Richard Hylen, Chairman and CEO, stated, “I received a commercial purchase order from United Opportunities, LLC on May 28, 2019 to manufacture 4 Cold-Water CBD/HEMP Extraction Systems for one of their customers in the amount of $2,880,000. Satel is now receiving additional MDU properties for DirecTV and Internet services.

  • GlobeNewswire

    SIML Increased Revenues and Assets -- $250M in Distribution Contracts

    San Francisco, California, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry announces the completion and disclosure filing of its audited annual financial statements post-merger and first-quarter financial statements for 2019. Prior to our merger Satel has been in operations for approximately 20 years as a privately held company.

  • GlobeNewswire

    Statement From the Chairman Richard Hylen

    San Francisco, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), the company announces that pursuant with the filing of our Form 10-KT for the period ending December 31, 2018, the Company will require additional time to complete the audit procedures based upon the facts that the merger took place in November 2018, and the issuer had changed its year-end from March 31 to December 31.  The Company was required to file the Form-10KT on or before March 31, 2019, and had filed an extension Form NT 10-K on April 1, 2019 for filing on or before April 16, 2019.  The company anticipates filing in the very near future once all of the audit procedures are complete. Richard Hylen, CEO and Chairman, stated, “Our merger took place in the fourth quarter of 2018, while the company changed its year-end filing date from March 31 to December 31.

  • GlobeNewswire

    Proscere Bioscience Announces $75M Distribution Agreement

    San Francisco, California, April 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), the company announces that its Cannabis Division, Proscere Bioscience, has signed a 5-year distribution agreement with Brand House Ventures in value of $75M to sell its Cold-Water Cannabis/Hemp Extraction Systems in the USA. On March 29, 2019, the Board of Directors approved the Company and its subsidiary, Proscere Bioscience Inc., to enter into an Exclusive Distribution Agreement with Brand House Ventures Inc. allowing the rights to sell the Cold-Water Cannabis/Hemp Extraction Systems within all of the United States.

  • GlobeNewswire

    SIML Reports Completion of Merger and Increase in Revenue

    GRASS VALLEY, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC Pink: SIML) ("Simlatus" or the "Company"), the Company announces that M&K CPA’s are on track to complete and file the annual audit ending December 31, 2019. Chairman and CEO, Richard Hylen, states, “First of all I want to thank our shareholders, noteholders, service providers and staff for the support and hard work required to complete the merger.

  • GlobeNewswire

    Simlatus-Satel-Proscere Bioscience Chairman Update: Canada – USA – Europe on the Horizon for CBD Extraction Systems

    Proscere Bioscience manufactures and distributes commercial cold-water CBD extraction systems. Richard Hylen, Chairman and CEO, stated, “We are on target for Europe, and we are negotiating contracts for Canada and the USA. Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact.

  • GlobeNewswire

    The Proscere Bioscience Division of Simlatus to Close Export CBD Deal in Europe -- a $225M Market Expectation

    Proscere Bioscience manufactures and distributes commercial cold-water CBD extraction systems. Richard Hylen further stated, “Our CBD extraction systems range from $750,000 for a high-end commercial system capable of 3000 gallons per day, to our low-end model costing $400,000. The company in Switzerland will receive an exclusive 5 year license with sell volume discounts of up to $50M per year.

  • GlobeNewswire

    Simlatus-Satel Group-Proscere Bioscience Announces European CBD Contract Negotiations

    San Francisco, California, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC Pink: SIML) (“Simlatus” or the “Company”), the company announces that its CBD division, Proscere Bioscience, is finalizing negotiations with a Switzerland based company to be granted exclusive rights in Europe to distribute the cold-water CBD extraction products. Chairman and CEO Richard Hylen stated, “I had recent meetings with the Switzerland based company in Los Angeles and look forward to disclosing the deal in the very near future. Switzerland is more advanced and ahead of the CBD market as compared to the United States, in both commercial and recreational applications, especially in the medical pharmaceutical markets.

  • GlobeNewswire

    Satel Group and Simlatus Acquire Proscere Bioscience and Their Exclusive Licensing Rights for Cold-Water CBD Extraction Technology; and Appoints Baron Tennelle and Victoria Boltrick to the Board of Directors

    San Francisco, California, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), Satel Group announced the merger with Simlatus in November 2018, and the merger resulted in the expansion of Satel’s San Francisco based internet business. Today, Satel Group and Simlatus announce the acquisition rights of cold-water CBD Extraction Technology and various agricultural products for the aeroponics industry. Richard Hylen, Chairman and CEO, stated, “We have a tremendous amount of excitement in announcing the acquisition of the technology and manufacturing of Cold-Water CBD Extraction systems.